Rimeporide in Patients With Duchenne Muscular Dystrophy (RIM4DMD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02710591
Recruitment Status : Completed
First Posted : March 17, 2016
Last Update Posted : February 9, 2018
Information provided by (Responsible Party):
EspeRare Foundation

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2017
  Actual Study Completion Date : February 2018